BetaDrugs BETA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do BETA
• Forcast & Targets BETA
• BETA Experts view
• Tomorrow's Movement BETA
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• BETA History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of BetaDrugs

Tomorrow's movement Prediction of Beta Drugs BETA appears to be in downtrend.

And this trend seems to be continuing further.

Price is below an important level of 2356.05 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Beta Drugs BETA made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Munafa value: 25 as on Wed 26 August 2026

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 2398 and price is deviating by 126 points

Upper Bollinger band is at 2649 and lower is at 2147, while middle bands are at 2273 and 2524

Price is coming down

Price is below 20day SMA

Price is in lower range of bands

Price action analysis of BetaDrugs (BETA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for BetaDrugs stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for BetaDrugs in short term but the sell signal is initial and weak.

BetaDrugs Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a buy signal for BetaDrugs in short term but BUY signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of BetaDrugs is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2381.32 and BetaDrugs BETA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the BetaDrugs BETA stock. Volume based technical analysis of BetaDrugs BETA stock is negative.

BetaDrugs Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Beta Drugs BETA

DMA (daily moving average) of Beta Drugs BETA

DMA period	DMA value
5 day DMA	2295.58
12 day DMA	2419.85
20 day DMA	2397.75
35 day DMA	2353.25
50 day DMA	2273.51
100 day DMA	1838.46
150 day DMA	1639.51
200 day DMA	1543.59

EMA (exponential moving average) of Beta Drugs BETA

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	2305.86	2328.28	2348.81
12 day EMA	2356.04	2373.31	2388.96
20 day EMA	2357.72	2367.9	2376.39
35 day EMA	2304.25	2306.8	2307.95
50 day EMA	2228.2	2226.86	2224.4

SMA (simple moving average) of Beta Drugs BETA

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	2295.58	2323.22	2336.78
12 day SMA	2419.85	2440.1	2447.31
20 day SMA	2397.75	2396.36	2387.49
35 day SMA	2353.25	2345.74	2339.51
50 day SMA	2273.51	2266.09	2257.06
100 day SMA	1838.46	1828.55	1817.57
150 day SMA	1639.51	1634.91	1630.23
200 day SMA	1543.59	1532.94	1522.13

Fundamentals, profit and EPS of Beta Drugs BETA

EPS is 40.92 and PE is: 55.25

Last quarter profit: (March 2026 quarter) 9.05 crores (-15.18%)

Debt: 147.80 in crores

Market capitalization: 2125.30

EPS is 41.51 and PE is: 54.47

Last quarter profit: (December 2025 quarter) 8.52 crores (-20.45%)

Debt: 145.76 in crores

Market capitalization: 1180.64

Videos related to: BetaDrugs BETA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI